1-Hexyl-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione

Catalog No. :
ACOHUG529
CAS No. :
1028-33-7
Molecular Formula :
C13H20N4O2
Molecular Weight :
264.33

IUPAC Name:1-hexyl-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione

1-Hexyl-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$69.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Hexyl-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione
IUPAC Name1-hexyl-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Molecular FormulaC13H20N4O2
Molecular Weight264.33
SMILESCN1C=NC(N(C(N2CCCCCC)=O)C)=C1C2=O
InChI KeyMRWQRJMESRRJJB-UHFFFAOYSA-N
SynonymCS-0318887 | CAS-1028-33-7 | 1-n-hexyltheobromine | DB13634 | 1H-Purine-2,6-dione, 3,7-dihydro-1-hexyl-3,7-dimethyl- | Pentifyllinum | SCHEMBL147256 | SK 7 (Pharmaceutical) | T4S08274OY | 1-Hexyltheobromide | 3,7-Dimethyl-1-hexyl-1H,3H-purin-2,6-dione | H
CAS No.1028-33-7
PubChem CID70569

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P233-P260-P261-P264-P271-P280-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOHUG529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKWU679 route compound structure diagram
    ACRKWU67983-67-0 In Stock
  4. Then
  5. ACOHUG529 route product structure diagram
    ACOHUG5291028-33-7
Inquiry

2. ACOHUG529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKWU679 route compound structure diagram
    ACRKWU67983-67-0 In Stock
  4. Then
  5. ACOHUG529 route product structure diagram
    ACOHUG5291028-33-7
Inquiry

Comments (0)